國家衛生研究院 NHRI:Item 3990099045/15280
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 908947      在线人数 : 1002
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15280


    题名: Development of seasonal influenza virus-like particle (VLP) vaccines using insect cell-based baculovirus expressing system
    作者: Badruzzaman, ATM;Cheng, YC;Sung, WC;Huang, CY;Lee, MS
    贡献者: National Institute of Infectious Diseases and Vaccinology
    摘要: Intro: Influenza viruses are highly infectious and cause widespread respiratory diseases. Moreover, it could pose a noteworthy epidemic and pandemic threat to public health. Vaccination is the most cost-effective intervention to prevent influenza and its complications. Currently, most commercial influenza vaccines are produced using embryonic chicken eggs (ECE), which is hard to scale up efficiently and could potentially reduce vaccine efficacy due to gene mutations in HA genes. In addition, the egg-based technology is associated with some jeopardy of allergic reactions and there is a risk of disrupted egg supply when avian influenza outbreaks erupt. To overcome the dependency on ECE, developments of influenza vaccines based on efficient and robust production platforms are urgently needed. Methods: Several potential vaccine production systems already have shown potential as replacers, including a virus-like particle (VLP) platform. In the current study, using a Baculovirus Expression System (BES), we engineered HA, NA, and M1 genes of influenza A/H1N1, A/H3N2, B/Yamagata-like, and B/Victoria-like virus strains (A/Hawaii/70/2019, A/Minnesota/41/2019, B/Brisbane/09/2014 & B/Brisbane/63/2014) to produce VLP vaccine antigens H1N1-VLP, H3N2-VLP, Yamagata-VLP, Victoria-VLP, respectively. Then functional and antigenic features were determined, including hemagglutination assay, protein composition, size, and morphology of the VLP antigens. Findings: We found that these recombinants VLPs contained influenza HA, NA, and M1 with functional activity, resembled influenza virions in morphology and size, and were structurally intact. We compared the immunogenicity of in-house VLP antigens and commercial recombinant HA (rHA) vaccines in mice. Results revealed that our recombinant VLP antigens are highly immunogenic and produced higher hemagglutination inhibition and virus neutralization antibody titers than the commercial rHA vaccine. Conclusion: The insect cell-based seasonal influenza VLP vaccine antigens are more immunogenic than rHA antigens. Further animal challenge studies are worth to conduct.
    日期: 2023-05
    關聯: International Journal of Infectious Diseases. 2023 May;130(Suppl. 2):S81-S82.
    Link to: http://dx.doi.org/10.1016/j.ijid.2023.04.202
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1201-9712&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001037898500191
    显示于类别:[李敏西] 會議論文/會議摘要
    [宋旺洲] 會議論文/會議摘要

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI001037898500191.pdf105KbAdobe PDF146检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈